Richard Champlin

Richard Champlin

UNVERIFIED PROFILE

Are you Richard Champlin?   Register this Author

Register author
Richard Champlin

Richard Champlin

Publications by authors named "Richard Champlin"

Are you Richard Champlin?   Register this Author

100Publications

3604Reads

44Profile Views

Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients.

J Med Virol 2020 Jan 3;92(1):86-95. Epub 2019 Sep 3.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.25574DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842396PMC
January 2020

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 Sep 10. Epub 2019 Sep 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.006DOI Listing
September 2019

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis.

Am J Hematol 2019 Jun 3;94(6):E176-E180. Epub 2019 Apr 3.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25470DOI Listing
June 2019

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.

Biol Blood Marrow Transplant 2019 05 11;25(5):1039-1044. Epub 2019 Jan 11.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791193002
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2019.01.009DOI Listing
May 2019

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.

Curr Res Transl Med 2019 May 23;67(2):51-55. Epub 2019 Jan 23.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.retram.2019.01.001DOI Listing
May 2019

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2019 03 9;25(3):505-514. Epub 2018 Oct 9.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183059
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.032DOI Listing
March 2019

Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma.

EBioMedicine 2019 Jan 10;39:612-620. Epub 2018 Dec 10.

Department of Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2018.12.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354702PMC
January 2019

Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation.

Br J Haematol 2018 12 19;183(5):831-835. Epub 2017 Dec 19.

Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15059DOI Listing
December 2018

Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells.

Exp Hematol 2018 11 10;67:49-59.e1. Epub 2018 Aug 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2018.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262883PMC
November 2018

CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes.

Biol Blood Marrow Transplant 2018 10 20;24(10):2017-2024. Epub 2018 Jun 20.

Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.06.016DOI Listing
October 2018

Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.

N Engl J Med 2018 10;379(15):1443-1451

From the Departments of Stem Cell Transplantation and Cellular Therapy (M.M., A.O., D.M., S.A., I.K., L.L., R.C., E.J.S., K.R.), Infectious Diseases (V.M.), Neuro-Oncology (S.T.), Diagnostic Radiology (T.L.C.), and Leukemia (A.F.), M.D. Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1801540
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1801540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283403PMC
October 2018

Neurocognitive deficits in older patients with cancer.

J Geriatr Oncol 2018 09 9;9(5):482-487. Epub 2018 Mar 9.

Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2018.02.010DOI Listing
September 2018

Overall survival in older patients with cancer.

BMJ Support Palliat Care 2018 Sep 22. Epub 2018 Sep 22.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2018-001516DOI Listing
September 2018

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.003DOI Listing
July 2018

Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.

J Exp Clin Cancer Res 2018 Jul 13;37(1):150. Epub 2018 Jul 13.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-018-0800-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044039PMC
July 2018

Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.

Transpl Int 2018 06 13;31(6):639-648. Epub 2018 Mar 13.

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/tri.13142
Publisher Site
http://dx.doi.org/10.1111/tri.13142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948153PMC
June 2018

Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.

Support Care Cancer 2018 May 2;26(5):1561-1568. Epub 2017 Dec 2.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3962-7DOI Listing
May 2018

Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma.

Qual Life Res 2018 Apr 19;27(4):979-985. Epub 2017 Dec 19.

Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-017-1759-2DOI Listing
April 2018

Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation.

Arch Osteoporos 2018 Apr 4;13(1):38. Epub 2018 Apr 4.

Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11657-018-0453-5DOI Listing
April 2018

Risk factors for falls in older patients with cancer.

BMJ Support Palliat Care 2018 Mar 31;8(1):34-37. Epub 2017 Aug 31.

Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2017-001388DOI Listing
March 2018

Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation.

Biol Blood Marrow Transplant 2018 02 3;24(2):353-358. Epub 2017 Oct 3.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.09.018DOI Listing
February 2018

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.

Biol Blood Marrow Transplant 2017 Dec 24;23(12):2166-2171. Epub 2017 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889108PMC
December 2017

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

Eur J Haematol 2017 Dec 8;99(6):532-535. Epub 2017 Oct 8.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12970DOI Listing
December 2017

The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells.

Leuk Lymphoma 2017 11 10;58(11):2705-2716. Epub 2017 Apr 10.

a Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1306647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526721PMC
November 2017

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.

Am J Surg Pathol 2017 Nov;41(11):1483-1490

Departments of *Stem Cell Transplantation and Cellular Therapy †Pathology ‡Gastroenterology, The University of Texas M.D. Anderson Cancer Center §Department of Pediatric Oncology, Baylor College of Medicine, Houston, TX ∥Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000914DOI Listing
November 2017

Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Expert Opin Drug Metab Toxicol 2017 Sep 17;13(9):901-923. Epub 2017 Aug 17.

b Department of Stem Cell Transplantation , The University of Texas M.D. Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2017.1360277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584057PMC
September 2017

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

Biol Blood Marrow Transplant 2017 Aug 12;23(8):1359-1366. Epub 2017 May 12.

Department of Stem Cell Transplantation and Cellular Therapy, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453532PMC
August 2017

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2017 Jul 4;23(7):1059-1063. Epub 2017 Apr 4.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.030DOI Listing
July 2017

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.

Cancer 2017 06 24;123(11):2025-2034. Epub 2017 Jan 24.

Center for International Blood and Marrow Transplantation (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30536DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445001PMC
June 2017

Prognostic Index for Critically Ill Allogeneic Transplantation Patients.

Biol Blood Marrow Transplant 2017 Jun 3;23(6):991-996. Epub 2017 Mar 3.

Department of Critical Care, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.003DOI Listing
June 2017

Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.

Eur J Haematol 2017 Mar 1;98(3):263-268. Epub 2016 Dec 1.

Department of Stem Cell Transplantation and Cellular therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12826DOI Listing
March 2017

Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2017 Feb 14;23(2):318-324. Epub 2016 Nov 14.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517662PMC
February 2017

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial.

Bonekey Rep 2016 19;5:843. Epub 2016 Oct 19.

Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bonekey.2016.72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154364PMC
October 2016